Start free trial
Trending New Genres Authors
EnglishEnglish
EspañolSpanish
简体中文Chinese
繁體中文Chinese (Traditional)
FrançaisFrench
DeutschGerman
日本語Japanese
PortuguêsPortuguese
ItalianoItalian
한국어Korean
РусскийRussian
NederlandsDutch
العربيةArabic
PolskiPolish
हिन्दीHindi
Tiếng ViệtVietnamese
SvenskaSwedish
ΕλληνικάGreek
TürkçeTurkish
ไทยThai
ČeštinaCzech
RomânăRomanian
MagyarHungarian
УкраїнськаUkrainian
IndonesiaIndonesian
DanskDanish
SuomiFinnish
БългарскиBulgarian
עבריתHebrew
NorskNorwegian
HrvatskiCroatian
CatalàCatalan
SlovenčinaSlovak
LietuviųLithuanian
SlovenščinaSlovenian
СрпскиSerbian
EestiEstonian
LatviešuLatvian
فارسیPersian
മലയാളംMalayalam
தமிழ்Tamil
اردوUrdu
Searching...
SoBrief
The Healing Factor - Vitamin C Against Disease

The Healing Factor - Vitamin C Against Disease

How to live longer and better
Humans cannot make vitamin C, but does that mean we need grams a day?
by Irwin Stone 2017 190 pages
3.50
4 ratings
Listen
Immersive
V2.3
Amazon Kindle Audible
Try Full Access for 3 Days
Unlock listening & more!
Continue

Key Takeaways

Read the missing-enzyme story as a hypothesis, not a diagnosis.

An evolutionary explanation. Stone argues that a primate ancestor lost the ability to make ascorbic acid in the liver. The missing enzyme, L-gulonolactone oxidase, completes the pathway that other mammals use to produce it from glucose. He places the mutation tens of millions of years ago and suggests that plentiful vitamin C in ancestral diets allowed the mutation to persist. Humans, in this account, inherited a metabolic limitation and must obtain vitamin C from outside the body.

A bold inference. Stone uses this history to challenge the idea that vitamin C is needed only in tiny amounts to prevent scurvy. He estimates that humans might need amounts comparable to those produced by other mammals. But the genetic explanation does not, by itself, establish an optimal human dose or show that extra vitamin C prevents disease.

Analysis

The evolutionary framing is powerful because it asks why humans depend on a nutrient that many other mammals manufacture. That question can generate useful experiments about metabolism and stress. The inferential leap is from a lost production pathway to the claim that present-day illness reflects a widespread shortage. Evolution does not preserve a single fixed nutritional target: diets, physiology, and environments change together. A missing enzyme establishes dependence on dietary intake, but the amount needed for ordinary health, or the benefit of doses far above sufficiency, requires separate evidence.

Distinguish overt scurvy from Stone's proposed hidden deficiency.

Two different conditions. Stone separates acute scurvy, the severe disease caused by prolonged deprivation, from what he calls hypoascorbemia: persistently low ascorbic acid that may impair normal body processes without producing classic scurvy. Acute scurvy can involve bleeding gums, bruising, weakness, poor wound healing, and fragile bones. Stone argues that lesser shortages could be harder to recognize and might reduce resistance to illness.

The diagnostic problem. He proposes that this hidden state is widespread and contributes to many other diseases. Yet the book does not establish a dependable test or threshold that can distinguish this proposed condition from ordinary variation or other causes of symptoms. Its central idea is that avoiding frank scurvy may not equal optimal health, but that proposition is broader than the evidence presented for it.

Analysis

The distinction between a disease's unmistakable endpoint and milder biological changes is a valuable medical question. Many conditions have a continuum of severity, and early dysfunction can escape routine diagnosis. Still, a continuum needs measurable landmarks. Fatigue, infection, or poor healing can arise for many reasons, so relabeling them as hidden vitamin deficiency risks making the hypothesis impossible to disprove. A useful version of Stone's proposal would specify biomarkers, thresholds, and outcomes in advance, then test whether correcting the measured abnormality improves health.

A clear trial can change practice, but institutions may take decades.

Lind's shipboard test. In 1747, naval surgeon James Lind divided twelve sailors with scurvy into six pairs and gave each pair a different proposed remedy. The two men who received oranges and lemons improved rapidly, while the other treatments did not produce comparable results. Lind had not identified ascorbic acid, but he had shown that citrus fruit could treat scurvy.

Evidence was not enough. The British Navy did not adopt lemon juice as a routine preventive measure until 1795. Stone says this delay cost many lives and presents the episode as a warning about entrenched practice. He also recounts Captain Cook's successful voyage, during which fresh produce and sauerkraut helped prevent scurvy. The history shows both the value of testing treatments against alternatives and the human cost when useful findings are not acted on.

Analysis

Lind's small experiment is memorable because its design made competing explanations visible: similar patients received different treatments, and outcomes diverged. It is an early example of comparative clinical reasoning, not a modern trial with large numbers or formal statistical analysis. The delay in adoption also illustrates that evidence moves through institutions, logistics, and professional judgment, not just journals. The caution cuts both ways: institutions can be slow to accept a useful treatment, but a neglected or unconventional claim is not automatically correct.

Dose is part of the question, not proof that more works.

Stone's dosage argument. The book says many early studies treated ascorbic acid as a trace nutrient and therefore tested doses of only tens or hundreds of milligrams. Stone contrasts these with his proposed daily intake of roughly 2 to 4 grams under low-stress conditions and about 15 grams under stress. He cites animal comparisons, clinical reports, and the work of physician Frederick Klenner, who used still larger amounts for serious viral illnesses.

A hypothesis, not a regimen. Stone's point is that a treatment cannot be ruled out if it has only been tested at doses too low to produce the intended effect. But his proposed amounts are not established recommendations. The book's examples do not consistently use controlled trials, and calculations based on animal production cannot settle a safe, effective human dose.

Analysis

Dose-response is a basic principle of pharmacology: too little of an active substance may fail to reveal an effect. Yet increasing a dose can also change absorption, side effects, and the balance of benefit and harm. For vitamin C, high oral intake can cause gastrointestinal problems, and individual medical circumstances matter. A credible test needs dose-finding studies, safety monitoring, and comparison groups, rather than assuming that a dose modeled on another species is therapeutic. Readers should not treat Stone's gram-level proposals as personal medical instructions.

Use collagen and redox biology to generate questions, not cures.

A plausible biological foundation. Stone emphasizes that vitamin C is needed to make collagen, a structural protein found in connective tissue, blood vessels, skin, and bone. This helps explain why severe deficiency causes fragile tissues and poor wound healing. He also describes ascorbic acid as part of oxidation-reduction chemistry, in which molecules transfer electrons, and connects it to enzyme activity and immune-cell function.

From mechanism to treatment. These roles lead Stone to propose benefits for wounds, fractures, vascular disease, infections, and aging. The biology makes those questions reasonable to investigate. It does not show that taking extra vitamin C beyond what the body needs will improve each condition. A mechanism can explain why deficiency is harmful without proving that high-dose supplementation reverses a complex disease.

Analysis

This section's strength is its effort to connect a nutrient's chemistry with recognizable bodily functions rather than treating it as a label on a food chart. Collagen formation gives a coherent account of classic scurvy symptoms, and redox chemistry helps explain why vitamin C participates in many reactions. The challenge is specificity: a molecule involved in numerous pathways is not necessarily a treatment for every illness touching those pathways. Clinical research must identify which patients, doses, and outcomes show a meaningful effect.

Judge each disease claim by its evidence, not its promise.

A wide-ranging casebook. Stone reviews studies and clinical reports involving colds, viral and bacterial infections, cancer, heart disease, strokes, arthritis, eye disorders, kidney problems, pregnancy, and mental illness. For example, he cites a ski-camp study in which fewer participants receiving one gram daily reported cold symptoms than those who did not. He also highlights laboratory findings suggesting that ascorbate affected cancer cells, while acknowledging that cancer research produced conflicting results.

Different evidence, different confidence. These examples range from laboratory experiments and animal studies to case reports and small clinical comparisons. Stone often treats them as promising leads that deserve larger trials. They do not amount to proof that vitamin C prevents or cures these diseases. The book's breadth is best read as a map of proposed research questions, not as a list of established treatments.

Analysis

The broad survey has a genuine virtue: it makes readers notice how one molecule can appear across many areas of physiology and medicine. But evidence has levels. A test tube result can reveal a mechanism, while a case report can suggest a possibility; neither reliably predicts benefit for patients. Modern evaluation asks whether controlled studies reproduce an effect, whether it matters clinically, and whether risks are acceptable. This is especially important for serious conditions, where an appealing supplement claim must not displace proven diagnosis or treatment.

Treat stress and individual variation as research variables, not dose calculators.

Needs may vary. Stone argues that many mammals increase their own ascorbic acid production during infection, injury, cold, heat, poisoning, or other stress. Humans cannot make that adjustment through the same pathway, so he proposes that illness or exposure could increase their need. He also invokes biochemical individuality, the idea that people may differ in how much of a nutrient they require.

Variation needs measurement. Stone notes that some people reported diarrhea, rashes, or stomach discomfort when taking ascorbic acid, and he suggests lowering doses or increasing them gradually. He also discusses smoking, surgery, pregnancy, and environmental toxins as possible sources of depletion. These are claims to test, not a practical method for calculating a person's dose. A stressful event does not establish that high-dose supplementation is necessary or safe.

Analysis

The idea that average requirements conceal meaningful differences is familiar in personalized medicine. Age, diet, illness, and metabolism can all matter, so fixed averages should not end scientific inquiry. But personalization requires validated measures that predict response. Without them, the language of individual need can encourage ever-higher doses without a clear stopping rule. Stone's attention to side effects is useful, while his broad claim of near-absence of toxicity should be treated cautiously, particularly when people have medical conditions or take other treatments.

Make the book's broad claims answerable with trials, not anecdotes.

A research program. Stone calls for coordinated studies rather than scattered experiments using different methods and doses. He wants researchers to establish appropriate intake levels, examine responses under stress, and test specific diseases with consistent protocols. He also proposes a morbidity index, a ratio comparing reduced ascorbic acid with its oxidized form, dehydroascorbic acid, as a possible way to track illness. The book presents this index as an idea requiring further validation.

What a test must show. A rigorous program would define who is studied, compare vitamin C with an appropriate control, monitor safety, and measure outcomes that matter to patients. Separate trials would be needed for separate conditions. That approach preserves Stone's useful challenge to neglected questions while refusing to turn suggestive observations into medical advice before they are replicated.

Analysis

This is the most durable lesson in the book: controversial health claims become useful when they are made testable. Standardized measures and controlled comparisons could determine whether a proposed dose helps, for whom, and at what cost. The suggested morbidity index also illustrates the need for validation: a biomarker must reliably distinguish disease states and predict outcomes before it guides care. A research agenda should be open to positive and negative results alike, rather than treating lack of confirmation as proof that the question was ignored.

Analysis

The book is both a scientific history and a sustained argument for high-dose vitamin C. Its narrative begins with an evolutionary claim, follows the discovery of ascorbic acid and the defeat of scurvy, then interprets decades of disease research as evidence that medicine has asked the wrong question. That structure is persuasive because each stage seems to support the next: humans lost a synthetic pathway, classic scurvy is only the visible extreme, and low-dose studies may miss effects that larger doses could reveal.

The strongest contribution is methodological. Stone insists that dose, timing, and physiological context matter, and he draws attention to the difference between laboratory findings, clinical observations, and decisive therapeutic evidence. His account of Lind also gives the reader a vivid lesson in controlled comparison and the danger of delayed adoption. These points remain valuable even when the book's medical conclusions are treated skeptically.

The central weakness is the distance between a plausible mechanism and a proven treatment. The argument moves from human inability to synthesize vitamin C to a proposed widespread deficiency, then from biochemical roles to benefits across many diseases. Each transition requires its own evidence. Reports involving small samples, animal models, uncontrolled cases, or in vitro cancer cells cannot establish that multigram dosing prevents strokes, treats infections, or extends life. The book itself repeatedly calls for the trials that would settle these questions, which reveals that many of its most dramatic claims remain proposals rather than conclusions.

The fairest reading is neither dismissal nor adoption. Stone offers a historically situated research program, not a reliable clinical handbook. The reader can retain the questions about metabolic variation, stress, and under-tested doses while demanding modern standards of replication, safety assessment, and patient-centered outcomes. For serious disease, this distinction is essential: curiosity about an adjunct is compatible with continuing evidence-based care, but a promising hypothesis should not be mistaken for a substitute.

Summary in 30 Seconds
Vitamin C is essential for collagen formation and other biological processes, while prolonged severe deficiency causes scurvy. Stone argues that humans' inability to synthesize it may mean ordinary intake is inadequate, especially during stress, but this does not establish a higher need or effective dose. He cites proposed intakes of 2 to 4 grams daily, rising to 15 grams under stress, as hypotheses rather than recommendations. Lind's 1747 comparison of citrus with other remedies helped demonstrate scurvy treatment, though adoption took decades. Disease claims require controlled trials, consistent methods, and safety monitoring.
Contains spoilers

Last updated:

Report Issue
Want to read the full book?

Glossary

hypoascorbemia

proposed chronic low ascorbate

Stone's name for a proposed condition of persistently low ascorbic acid, linked in his argument to the inherited inability to synthesize it. He distinguishes it from acute clinical scurvy, suggesting that milder shortages may impair health without classic symptoms. The book's broad claims about its prevalence and role in other diseases are hypotheses, not established diagnoses.

megascorbic prophylaxis

proposed high-dose prevention

Stone's term for using amounts of ascorbic acid well above ordinary dietary levels in an effort to prevent illness or increase resistance to stress. He proposes regular intake for baseline health and larger amounts during exposures such as infection or injury. The book advocates research into this approach, but its proposed doses should not be read as proven preventive guidance.

megascorbic therapy

proposed high-dose treatment

Stone's term for treating disease with large amounts of ascorbic acid, sometimes by frequent oral doses and sometimes by injection. He argues that low-dose studies may not test the substance at levels needed for pharmacological effects. The clinical reports he reviews are uneven in quality, and the term describes an approach under investigation rather than an established treatment category.

orthomolecular medicine

treatment using bodily substances

A medical approach, described in the book through Linus Pauling's work, that seeks to prevent or treat disease by providing substances normally present in the body at proposed optimal concentrations. These substances can include vitamins, amino acids, and other metabolites. The framework supplies a rationale for high-dose nutrient research, but each substance, dose, and disease still requires evidence of safety and benefit.

L-gulonolactone oxidase

enzyme for vitamin C synthesis

The enzyme that carries out the final step enabling most mammals to synthesize ascorbic acid from glucose in the liver. Stone argues that a mutation disabling this enzyme in a primate ancestor left humans and some other primates dependent on dietary vitamin C. Its absence explains that dependence, but does not by itself determine an optimal intake.

biochemical individuality

variation in nutrient requirements

A concept Stone attributes to Roger J. Williams, proposing that people can differ substantially in their needs for, and use of, nutrients and metabolites. Stone uses it to question whether a single average intake is adequate for everyone. The idea supports studying individual variation, but useful personalization requires reliable measurements and evidence linking them to health outcomes.

morbidity index

proposed ascorbate ratio

Stone's proposed measure comparing reduced ascorbic acid with dehydroascorbic acid, its oxidized form, in blood. He suggests that the balance might reflect illness severity and recovery more clearly than a total vitamin C measurement. The book presents the index as a possible diagnostic and prognostic tool, not as a validated clinical test.

Download PDF

To save this The Healing Factor - Vitamin C Against Disease summary for later, download the free PDF. You can print it out, or read offline at your convenience.
Download PDF
File size: 0.27 MB     Pages: 13

Download EPUB

To read this The Healing Factor - Vitamin C Against Disease summary on your e-reader device or app, download the free EPUB. The .epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.
Download EPUB
File size: 1.35 MB     Pages: 16
Want to read the full book?
Follow
Listen1 mins
Home
Swipe
Library
Get App
Try Full Access for 3 Days
Listen, bookmark, and more
Compare Features Free Pro
📖 Read Summaries
Read unlimited summaries. Free users get 3 per month
🎧 Listen to Summaries
Listen to unlimited summaries in 40 languages
—
❤️ Unlimited Bookmarks
Free users are limited to 4
—
📜 Unlimited History
Free users are limited to 4
—
📥 Unlimited Downloads
Free users are limited to 1
—
Risk-Free Timeline
Today: Get Instant Access
Listen to full summaries of 26,000+ books. That's 12,000+ hours of audio!
Day 2: Trial Reminder
We'll send you a notification that your trial is ending soon.
Day 3: Your subscription begins
You'll be charged on Nov 24,
cancel anytime before.
Consume 2.8× More Books
2.8× more books Listening Reading
Our users love us
1M+ readers
Trustpilot Rating
TrustPilot
4.6 Excellent
This site is a total game-changer. I've been flying through book summaries like never before. Highly, highly recommend.
— Dave G
Worth my money and time, and really well made. I've never seen this quality of summaries on other websites. Very helpful!
— Em
Highly recommended!! Fantastic service. Perfect for those that want a little more than a teaser but not all the intricate details of a full audio book.
— Greg M
Save 62%
Yearly
$119.88 $44.99/year/yr
$3.75/mo
Monthly
$9.99/mo
Start a 3-Day Free Trial
3 days free, then $44.99/year. Cancel anytime.
Unlock a world of fiction & nonfiction books
26,000+ books for the price of 2 books
Read any book in 10 minutes
Discover new books like Tinder
Request any book if it's not summarized
Read more books than anyone you know
#1 app for book lovers
Lifelike & immersive summaries
30-day money-back guarantee
Download summaries in EPUBs or PDFs
Cancel anytime in a few clicks

Why one summary?

Scanner
Find a barcode to scan

⭐
⭐
⭐
We have a special gift for you
Open
38% off
DISCOUNT FOR YOU
⭐
⭐
⭐
$79.99
$49.99/year
Only $4.16 per month
Continue
2 taps to start, super easy to cancel
Settings
General
Widget
Loading...